Citrate, Drug Exposure

Created

2021-05-12

Last Modified

Files

1 Download↓
rx_2021_05_CitrateExposures_V1.csv (324.86 KB)
↓

Tags

Level of Review

Data Model

Abstract

Concept set intended to identify patients with an exposure to a citric acid compound.

Affiliation(s)

Children's Hospital of Philadelphia

Funder(s)

Provenance

A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 (PHYOX2) (Dicerna)

Description

This medication concept set includes the ingredients trisodium citrate, sodium citrate, and potassium citrate, and all of their descendants. Combinations are included. It was developed by taking the RxNorm descendants of 19065826 (trisodium citrate), 977968 (sodium citrate), and 976545 (potassium citrate) and excluding the search terms “cream”, “ointment”, “buccal”, “topical”, “duralock”, “ophthalmic”, “glucose”, “dextromethorphan”, “injectable”. This concept set was intended to investigate medication usage of patients with primary hyperoxaluria (PH) before and after diagnosis of PH, specifically for management of kidney stones. It was intended to contain non-topical and non-IV formulations of trisodium citrate, sodium citrate, and potassium citrate. This concept set contains only RxNorm and RxNorm Extension codes.

Development Code

Vocabulary

Medication Classification Level










Clinical Subjects Headings

Data Source

Related Phenotype

Related Person

Related Study

Thumbnail Image
A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 (PHYOX2)
Children's Hospital of Philadelphia; Dicerna Pharmaceuticals (United States)
This study was intended to generate new knowledge about the impact of Primary Hyperoxaluria (PH) on kidney function and characterize the clinical course for children with PH.

Related Concept Set

Related Publications

Creative Commons license

a CC-BY Attribution 4.0 License.
Except where otherwised noted, this item's license is described as a CC-BY Attribution 4.0 License.